FDA Requests Comment on Proposed Collection of Information for Systemic Antibacterial Drug Products and Antimicrobial Susceptibility Testing Devices

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed information collection related to labeling for susceptibility test information in systemic antibacterial drug products and antimicrobial susceptibility testing devices, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.